Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 252 results found. Search for [ pfizer vaccine efficacy ]

Results 1 to 21 of 252
Reuters
March 1, 2021
Providing a final clearance for the vaccine a day after it was authorized by U.S. regulators, the Advisory Committee on Immunization Practices (ACIP) voted 12-0 to recommend the vaccine from J&J as appropriate for Americans 18 and older


PTI
February 28, 2021
China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the US drug regulator


Associated Press
February 27, 2021
The Food and Drug Administration is expected to quickly follow the recommendation and make J&J's shot the third vaccine authorised for emergency use in the US


BusinessToday.In
February 25, 2021
The real-world study involved around 1.2 million people in Israel. Pfizer vaccine has also proved to be effective against B.1.1.7 variant, also known as the UK variant of coronavirus


Reuters
February 19, 2021
Phil Dormitzer, one of Pfizer's top viral vaccine scientists, said in an interview that he believes the current vaccine is highly likely to still protect against the concerning variant first discovered in South Africa


Reuters
February 18, 2021
Pfizer and BioNTech said they were doing similar lab work to understand whether their vaccine is effective against another variant first found in Brazil


BusinessToday.In
February 17, 2021
Saying that vaccination is necessary to fight the pandemic, Guleria urged people to not be afraid of the vaccine as it is totally safe.


PTI
February 17, 2021
The vaccines currently approved for emergency use in India are Covishield, from the Oxford-AstraZeneca stable manufactured by Pune's Serum Institute of India, and Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology (NIV)


Chitranjan Kumar
February 15, 2021
COVID-19 vaccine: The AstraZeneca-Oxford product is a viral vectored vaccine called ChAdOx1-S [recombinant], which is being produced at several manufacturing sites, as well as in the Republic of Korea and India


Reuters
February 15, 2021
South Korea had said it would complete vaccinations on 1.3 million people by the first quarter of this year with AstraZeneca shots, but it slashed the target sharply to 750,000


Associated Press
February 14, 2021
The announcement comes after a government panel on Friday confirmed that final results of clinical testing done in Japan showed that the vaccine had an efficacy similar to what overseas tests showed


BusinessToday.In
February 9, 2021
WHO highlighted the need to reduce virus circulation and prevent infections so that it reduces the opportunities for coronavirus to mutate further.


PTI
February 9, 2021
The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants carrying the N501Y and E484K mutations


BusinessToday.In
February 8, 2021
Coronavirus vaccine: Sarah Gilbert, professor of vaccinology at Oxford told BBC that the researchers have already started working on the first part of the manufacturing process


Reuters
February 8, 2021
Prior to widespread circulation of the more contagious variant, the vaccine was showing efficacy of around 75%, researchers said


Reuters
February 4, 2021
The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world


Associated Press
January 30, 2021
Vaccines are not yet approved for children, but testing already is underway for those as young as 12


Reuters
January 29, 2021
Serum expected a decision on an Indian trial of Novavax's vaccine soon, Chief Executive Adar Poonawalla said, hours after the US company reported the efficacy data


BusinessToday.In
January 28, 2021
The European Medicines Agency is expected to give its long-awaited approval to AstraZeneca's COVID-19 vaccine on Friday


BusinessToday.In
January 28, 2021
The European Medicines Agency is expected to give its long-awaited approval to AstraZeneca's COVID-19 vaccine on Friday


PAGES 1 OF 13  12345